Why the study?
Does digoxin reduce mortality or hospitalization in patients with chronic heart failure?
Does digoxin reduce mortality or hospitalization in patients with chronic heart failure?
Digoxin reduces hospitalizations but not overall mortality in patients with chronic heart failure.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
““Really, the only definitive treatment for rheumatic mitral valve stenosis is an intervention, either with balloon valvuloplasty or surgery, but I think these results are encouraging in that digoxin can be an important adjunctive therapy in rheumatic heart disease.””
Digoxin may reduce HF hospitalizations without mortality benefit; supports adjunctive use while leaving optimal modern integration open.
Digoxin did not reduce overall mortality, but it reduced the rate of hospitalization both overall and for worsening heart failure. These findings define more precisely the role of digoxin in the management of chronic heart failure.
No takes yet. Share an insight, caveat, or question.
The Digitalis Investigation Group (1997) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: